<i>MUC5</i><scp><i>AC</i></scp> hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer

  • Florence Renaud
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Audrey Vincent
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Christophe Mariette
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Michel Crépin
    Department of Molecular Oncology and Genetics Biochemistry and Molecular Biology Institute, Biology Pathology Center, Lille University Hospital Lille France
  • Laurence Stechly
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Stéphanie Truant
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Marie‐Christine Copin
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Nicole Porchet
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Emmanuelle Leteurtre
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Isabelle Van Seuningen
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France
  • Marie‐Pierre Buisine
    Inserm, UMR837, Team 5 “Mucins, Epithelial Differentiation and Carcinogenesis,” Jean‐Pierre Aubert Research Center Lille France

Description

<jats:p>Colorectal cancers (CRC) with microsatellite instability (MSI) display unique clinicopathologic features including a mucinous pattern with frequent expression of the secreted mucins MUC2 and MUC5AC. The mechanisms responsible for this altered pattern of expression remain largely unknown. We quantified DNA methylation of mucin genes (<jats:italic>MUC2</jats:italic>, <jats:italic>MUC5AC</jats:italic>, <jats:italic>MUC4</jats:italic>) in colonic cancers and examined the association with clinicopathological characteristics and molecular (MSI, <jats:italic>KRAS</jats:italic>, <jats:italic>BRAF,</jats:italic> and <jats:italic>TP53</jats:italic> mutations) features. A control cohort was used for validation. We detected frequent hypomethylation of <jats:italic>MUC2</jats:italic> and <jats:italic>MUC5AC</jats:italic> in CRC. <jats:italic>MUC2</jats:italic> and <jats:italic>MUC5AC</jats:italic> hypomethylation was associated with MUC2 and MUC5AC protein expression (<jats:italic>p</jats:italic> = 0.004 and <jats:italic>p</jats:italic> < 0.001, respectively), poor differentiation (<jats:italic>p</jats:italic> = 0.001 and <jats:italic>p</jats:italic> = 0.007, respectively) and MSI status (<jats:italic>p</jats:italic> < 0.01 and <jats:italic>p</jats:italic> < 0.001, respectively). Interestingly, <jats:italic>MUC5AC</jats:italic> hypomethylation was specific to MSI cancers. Moreover, it was significantly associated with <jats:italic>BRAF</jats:italic> mutation and CpG island methylator phenotype (<jats:italic>p</jats:italic> < 0.001 and <jats:italic>p</jats:italic> < 0.001, respectively). All these results were confirmed in the control cohort. In the multivariate analysis, <jats:italic>MUC5AC</jats:italic> hypomethylation was a highly predictive biomarker for MSI cancers. <jats:italic>MUC5AC</jats:italic> demethylation appears to be a hallmark of MSI in CRC. Determination of <jats:italic>MUC5AC</jats:italic> methylation status may be useful for understanding and predicting the natural history of CRC.</jats:p>

Journal

Citations (1)*help

See more

Report a problem

Back to top